BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25540764)

  • 1. Comparison of intravitreal bevacizumab with macular photocoagulation for treatment of diabetic macular edema: a systemic review and Meta-analysis.
    Liu XD; Zhou XD; Wang Z; Shen HJ
    Int J Ophthalmol; 2014; 7(6):1048-55. PubMed ID: 25540764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab with or without triamcinolone acetonide for diabetic macular edema: a meta-analysis of randomized controlled trials.
    Liu X; Zhou X; Wang Z; Li T; Jiang B
    Chin Med J (Engl); 2014; 127(19):3471-6. PubMed ID: 25269916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
    Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
    Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
    Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA
    Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Intravitreal Bevacizumab with or without Macular Photocoagulation for Diabetic Macular Edema: A Meta-Analysis.
    Xiao K; Weng SJ; Liang SZ; Wang J; Qian C; Wan GM
    Diabetes Ther; 2018 Dec; 9(6):2369-2381. PubMed ID: 30390227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema.
    Faghihi H; Roohipoor R; Mohammadi SF; Hojat-Jalali K; Mirshahi A; Lashay A; Piri N; Faghihi Sh
    Eur J Ophthalmol; 2008; 18(6):941-8. PubMed ID: 18988166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Abo-Elenin M
    Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal Diclofenac plus Bevacizumab versus Bevacizumab alone in treatment-naive diabetic macular edema: a randomized double-blind clinical trial.
    Ghanbari H; Kianersi F; Sonbolestan SA; Abtahi MA; Akbari M; Abtahi ZA; Abtahi SH
    Int Ophthalmol; 2017 Aug; 37(4):867-874. PubMed ID: 27624173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency and safety of laser photocoagulation with or without intravitreal ranibizumab for treatment of diabetic macular edema: a systematic review and Meta-analysis.
    Qian TW; Zhao MY; Li XX; Xu X
    Int J Ophthalmol; 2017; 10(7):1134-1143. PubMed ID: 28730118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab injection alone or combined with triamcinolone versus macular photocoagulation in bilateral diabetic macular edema; application of bivariate generalized linear mixed model with asymmetric random effects in a subgroup of a clinical trial.
    Yaseri M; Zeraati H; Mohammad K; Soheilian M; Ramezani A; Eslani M; Peyman GA
    J Ophthalmic Vis Res; 2014; 9(4):453-60. PubMed ID: 25709771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial.
    Ahmadieh H; Nourinia R; Hafezi-Moghadam A; Sabbaghi H; Nakao S; Zandi S; Yaseri M; Tofighi Z; Akbarian S
    Br J Ophthalmol; 2019 Jul; 103(7):922-927. PubMed ID: 30150280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Intravitreal Anti-Vascular Growth Factor Agents With or Without Macular Photocoagulation on Diabetic Macular Edema: A Systematic Review and Meta-Analysis.
    Cui L; Jiao B; Han Q
    Diabetes Ther; 2019 Aug; 10(4):1283-1296. PubMed ID: 31079358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial.
    Riazi-Esfahani M; Riazi-Esfahani H; Ahmadraji A; Karkhaneh R; Mahmoudi A; Roohipoor R; Ghasemi F; Yaseri M
    Int Ophthalmol; 2018 Apr; 38(2):585-598. PubMed ID: 28349504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema.
    Soheilian M; Garfami KH; Ramezani A; Yaseri M; Peyman GA
    Retina; 2012 Feb; 32(2):314-21. PubMed ID: 22234244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular laser photocoagulation with or without intravitreal triamcinolone pretreatment for diabetic macular edema: a result from five randomized controlled trials.
    Liu XD; Zhou XD; Wang Z; Shen YM
    Int J Ophthalmol; 2016; 9(1):132-8. PubMed ID: 26949623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of intravitreal bevacizumab and erythropoietin versus intravitreal bevacizumab alone for refractory diabetic macular edema: a randomized double-blind clinical trial.
    Entezari M; Flavarjani ZK; Ramezani A; Nikkhah H; Karimi S; Moghadam HF; Daftarian N; Yaseri M
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2375-2380. PubMed ID: 31401683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short term effect of intravitreal bevacizumab for diabetic macular edema associated with epiretinal membrane.
    Maryam AK; Tafgeh M; Mahmoud M; Pasha A; Ahad S; Khalil GF
    Rom J Ophthalmol; 2018; 62(3):212-216. PubMed ID: 30505990
    [No Abstract]   [Full Text] [Related]  

  • 18. Using skew-symmetric mixed models for investigating the effect of different diabetic macular edema treatments by analyzing central macular thickness and visual acuity responses.
    Mansourian M; Kazemnejad A; Kazemi I; Zayeri F; Soheilian M
    J Res Med Sci; 2011 Oct; 16(10):1319-25. PubMed ID: 22973326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-Year Results of a Trial Comparing 2 Doses of Intravitreal Ziv-aflibercept versus Bevacizumab for Treatment of Diabetic Macular Edema.
    Jabbarpoor Bonyadi MH; Baghi A; Ramezani A; Yaseri M; Soheilian M
    Ophthalmol Retina; 2018 May; 2(5):428-440. PubMed ID: 31047323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: a meta-analysis.
    Zhang XL; Chen J; Zhang RJ; Wang WJ; Zhou Q; Qin XY
    Int J Ophthalmol; 2013; 6(4):546-52. PubMed ID: 23991395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.